Serum Institute seeks emergency use authorisation for its rBCG tuberculosis vaccine

The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII). India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/F5BGoaq
via IFTTT